Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?

Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA(2)DS(2)-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the conditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Paulo Eduardo Ocke, Lima, Marcos Cesar Braga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2020
Materias:
Innovations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202192/
https://www.ncbi.nlm.nih.gov/pubmed/34178079
http://dx.doi.org/10.1590/1677-5449.200057
Descripción
Sumario:Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA(2)DS(2)-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient’s condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality.

Ejemplares similares